BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7782162)

  • 1. 'Tethered ligand' derived pentapeptide agonists of thrombin receptor: a study of side chain requirements for human platelet activation and GTPase stimulation.
    Natarajan S; Riexinger D; Peluso M; Seiler SM
    Int J Pept Protein Res; 1995 Feb; 45(2):145-51. PubMed ID: 7782162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor.
    Chao BH; Kalkunte S; Maraganore JM; Stone SR
    Biochemistry; 1992 Jul; 31(27):6175-8. PubMed ID: 1320929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
    Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
    Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity studies of the thrombin receptor activating peptide.
    Sabo T; Gurwitz D; Motola L; Brodt P; Barak R; Elhanaty E
    Biochem Biophys Res Commun; 1992 Oct; 188(2):604-10. PubMed ID: 1332704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
    Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
    Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal sequence requirement of thrombin receptor agonist peptide.
    Hui KY; Jakubowski JA; Wyss VL; Angleton EL
    Biochem Biophys Res Commun; 1992 Apr; 184(2):790-6. PubMed ID: 1315534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies.
    Ceruso MA; McComsey DF; Leo GC; Andrade-Gordon P; Addo MF; Scarborough RM; Oksenberg D; Maryanoff BE
    Bioorg Med Chem; 1999 Nov; 7(11):2353-71. PubMed ID: 10632045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist.
    Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S
    Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity analysis of synthetic alpha-thrombin-receptor-activating peptides.
    Van Obberghen-Schilling E; Rasmussen UB; Vouret-Craviari V; Lentes KU; Pavirani A; Pouysségur J
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):667-71. PubMed ID: 7686363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides.
    Vassallo RR; Kieber-Emmons T; Cichowski K; Brass LF
    J Biol Chem; 1992 Mar; 267(9):6081-5. PubMed ID: 1313429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
    Lau LF; Pumiglia K; Côté YP; Feinstein MB
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of potent thrombin receptor antagonist peptides.
    Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
    J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand.
    Moschonas IC; Kellici TF; Mavromoustakos T; Stathopoulos P; Tsikaris V; Magafa V; Tzakos AG; Tselepis AD
    Platelets; 2017 Dec; 28(8):812-821. PubMed ID: 28267389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment.
    Norton KJ; Scarborough RM; Kutok JL; Escobedo MA; Nannizzi L; Coller BS
    Blood; 1993 Oct; 82(7):2125-36. PubMed ID: 8400262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles of two consecutive phenylalanine residues in thrombin receptor-tethered ligand peptides (SFFLRNP) in thrombin receptor activation.
    Shimohigashi Y; Nose T; Okazaki M; Satoh Y; Ohno M; Costa T; Shimizu N; Ogino Y
    Biochem Biophys Res Commun; 1994 Aug; 203(1):366-72. PubMed ID: 8074680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterocycle-peptide hybrid compounds. Aminotriazole-containing agonists of the thrombin receptor (PAR-1).
    McComsey DF; Hawkins MJ; Andrade-Gordon P; Addo MF; Oksenberg D; Maryanoff BE
    Bioorg Med Chem Lett; 1999 May; 9(10):1423-8. PubMed ID: 10360749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase.
    Seiler SM; Michel IM; Fenton JW
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1296-302. PubMed ID: 1371679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin receptor antagonists; recent advances in PAR-1 antagonist development.
    Anderluh M; Dolenc MS
    Curr Med Chem; 2002 Jul; 9(13):1229-50. PubMed ID: 12052165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.